D.E. Shaw & Co’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$215M Buy
5,842,000
+170,900
+3% +$8.1M 0.13% 177
2025
Q4
$289M Buy
5,671,100
+3,163,600
+126% +$162M 0.16% 120
2025
Q3
$139M Buy
2,507,500
+867,000
+53% +$50.7M 0.08% 299
2025
Q2
$113M Buy
1,640,500
+564,800
+53% +$38.4M 0.08% 302
2025
Q1
$74.7M Buy
1,075,700
+469,500
+77% +$38.8M 0.07% 350
2024
Q4
$52.1M Buy
606,200
+520,400
+607% +$56.3M 0.04% 558
2024
Q3
$10.2M Buy
85,800
+72,800
+560% +$9.71M 0.01% 1416
2024
Q2
$1.86M Hold
13,000
﹤0.01% 2717
2024
Q1
$1.67M Sell
13,000
-77,000
-86% -$9.17M ﹤0.01% 2761
2023
Q4
$9.31M Buy
90,000
+13,000
+17% +$1.29M 0.01% 1415
2023
Q3
$7M Hold
77,000
0.01% 1542
2023
Q2
$6.23M Buy
77,000
+59,800
+348% +$4.89M 0.01% 1703
2023
Q1
$1.37M Buy
+17,200
New +$1.22M ﹤0.01% 2946

Other funds holding NVO